Medical sodium hyaluronate gel dressing and preparation method thereof
Through oxidative degradation and enzymatic degradation technology combined with ultrasonic mixing and nanomembrane concentration technology, sodium hyaluronate gel dressing with uniform molecular weight grade was prepared, which solved the problem of narrow molecular weight distribution of existing products and achieved soothing and synchronizing internal and external skin. The moisturizing effect significantly improves moisturizing performance.
Patent Information
- Application Number
- CN202411135796.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-19
Smart Images

Figure BDA0004999393350000111
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomaterials and relates to a medical sodium hyaluronate gel dressing and a preparation method thereof. Background Art
[0002] Sodium hyaluronate (HA) is a high-molecular mucopolysaccharide that is widely present in human skin and other tissues and has a good moisturizing effect. The repair patch made from sodium hyaluronate is suitable for skin care after minimally invasive surgery such as facial laser and photorejuvenation. It can reduce pigmentation, lighten scars, and promote the repair of skin damage.
[0003] HA is mostly produced and used in the form of sodium hyaluronate. The efficacy of different types of sodium hyaluronate varies greatly. For example, high molecular weight sodium hyaluronate (molecular weight>500,000) has a good mucosal protective effect, while low molecular weight sodium hyaluronate (molecular weight 10,000-500,000) and oligomeric sodium hyaluronate (molecular weight <10,000) have good advantages in skin penetration and oral absorption. At present, hyaluronic acid products are mainly concentrated in hyaluronic acid with a single molecular weight distribution, with a narrow molecular weight distribution width and uneven quality. Summary of the invention
[0004] The present invention relates to a medical sodium hyaluronate gel dressing and a preparation method thereof, and belongs to the technical field of biomaterials. The specific components of the medical sodium hyaluronate gel dressing disclosed in the present invention are sodium hyaluronate, sodium chloride, carbomer and purified water, wherein the preparation method of sodium hyaluronate is as follows: (1) sodium hyaluronate solid is put into an oxidizing solvent for mixing, heating and keeping warm to obtain solution a; (2) sodium hyaluronate solid is mixed with a buffer solution, and then a degrading enzyme is added to obtain solution b after degradation; (3) sodium hyaluronate solid is made into a solution, ultrasonically mixed with solution a and solution b, and then filtered and separated, and dried to obtain sodium hyaluronate. The present invention oxidizes and degrades sodium hyaluronate and enzymolysis process, and then mixes it with a raw material solution. Sodium hyaluronate has different molecular weights from low to high, which simultaneously promotes the effects of soothing and hydrating from the inside and outside of the skin.
[0005] The purpose of the present invention can be achieved by the following technical solutions:
[0006] A medical sodium hyaluronate gel dressing, which is composed of the following raw materials in parts by weight: 0.05-0.5 parts of sodium hyaluronate, 0.01-0.1 parts of sodium chloride, 0.5-5 parts of carbomer, and 95-100 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps:
[0007] (1) placing sodium hyaluronate solid into an oxidizing solvent, mixing, heating and maintaining the temperature to obtain solution a;
[0008] (2) mixing sodium hyaluronate solid with a buffer solution, and then adding a degrading enzyme to obtain a solution b after degradation;
[0009] (3) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is ultrasonically mixed with solution a and solution b, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
[0010] Furthermore, the molecular weight of the sodium hyaluronate solid is 1-2 million, the solid-liquid ratio of the sodium hyaluronate solid to the oxidizing solvent in the step (1) is 0.1-0.2 g:1 mL, wherein the oxidizing solvent is a hydrogen peroxide solution, the mass concentration of the hydrogen peroxide solution is 2-3%, and the insulation temperature and time are 70-75° C. and 24-30 h, respectively.
[0011] Furthermore, in the step (2), the solid-to-liquid ratio of sodium hyaluronate solid to buffer solution is 80-90 g:1 L, the mass ratio of sodium hyaluronate solid to degradation enzyme is 100:0.01-0.026, wherein the degradation enzyme is composed of β-glucuronidase and β-N-acetylglucosaminidase in a mass ratio of 1:1, and the degradation time and temperature are 1-2 h and 35-37 ° C, respectively.
[0012] Furthermore, the preparation method of the buffer solution in step (2) is: disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride are dissolved in deionized water, and stirred at room temperature until all are dissolved to obtain a buffer solution.
[0013] Furthermore, the solid-liquid ratio of the total mass of the disodium hydrogen phosphate dihydrate, the disodium hydrogen phosphate dodecahydrate and the sodium chloride to deionized water is 9-10g:1L, wherein the mass ratio of the disodium hydrogen phosphate dihydrate, the disodium hydrogen phosphate dodecahydrate and the sodium chloride is 0.045:0.5-0.6:8.5-9.
[0014] Furthermore, in the step (3), the mass concentration of the sodium hyaluronate solution is 0.5-1.5%, and the volume ratio of the sodium hyaluronate solution, solution a and solution b is 5-10:2:2.
[0015] Furthermore, in the step (3), the ultrasonic time and frequency are 30-45 min and 40-60 kHz respectively, the drying temperature and time are 50-60° C. and 1-2 h respectively, and the pore size of the nanomembrane is 0.1-0.4 nm.
[0016] Furthermore, the preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 85°C±5°C while stirring. After all the water is dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 40°C±5°C while stirring, and sodium chloride is added, and the mixture is stirred for another 10 minutes.
[0017] Beneficial effects of the present invention:
[0018] 1. The present invention uses oxidation degradation and enzymatic hydrolysis processes to degrade sodium hyaluronate, thereby reducing its molecular weight to achieve the purpose of degradation. The β-glucuronidase and β-N-acetylglucosaminidase in the enzymatic hydrolysis process work together to degrade sodium hyaluronate to obtain a smaller molecular weight, which is then mixed with the raw material solution to allow sodium hyaluronate to have different molecular weight grades from low to high. Therefore, in the sodium hyaluronate gel dressing prepared by the present invention, the small molecular weight enters the skin, while the large molecular weight sodium hyaluronate forms a protective film on the surface of the skin, thereby simultaneously promoting the soothing and hydrating effects from the inside and outside. DETAILED DESCRIPTION
[0019] In order to further illustrate the technical means and effects adopted by the present invention to achieve the predetermined invention purpose, the specific implementation methods, structures, features and effects of the present invention are described in detail below in combination with embodiments.
[0020] Example 1
[0021] A medical sodium hyaluronate gel dressing, the medical sodium hyaluronate gel dressing is composed of the following raw materials in parts by weight: 0.05 parts of sodium hyaluronate, 0.01 parts of sodium chloride, 0.5 parts of carbomer, and 95 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps:
[0022] (1) placing sodium hyaluronate solid into an oxidizing solvent, mixing, heating and maintaining the temperature to obtain solution a;
[0023] (2) mixing sodium hyaluronate solid with a buffer solution, and then adding a degrading enzyme to obtain a solution b after degradation;
[0024] (3) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is ultrasonically mixed with solution a and solution b, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
[0025] The molecular weight of the sodium hyaluronate solid is 1 million, the solid-to-liquid ratio of the sodium hyaluronate solid to the oxidizing solvent in the step (1) is 0.1 g:1 mL, wherein the oxidizing solvent is a hydrogen peroxide solution, the mass concentration of the hydrogen peroxide solution is 2%, and the insulation temperature and time are 70° C. and 30 h, respectively.
[0026] In the step (2), the solid-liquid ratio of sodium hyaluronate solid to buffer solution is 80 g:1 L, the mass ratio of sodium hyaluronate solid to degradation enzyme is 100:0.01, wherein the degradation enzyme is composed of β-glucuronidase and β-N-acetylglucosaminidase in a mass ratio of 1:1, and the degradation time and temperature are 1 h and 35° C., respectively.
[0027] The preparation method of the buffer solution in step (2) is as follows: disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride are dissolved in deionized water, and stirred at room temperature until all are dissolved to obtain a buffer solution.
[0028] The solid-liquid ratio of the total mass of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride to deionized water is 9g:1L, wherein the mass ratio of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride is 0.045:0.5:8.5.
[0029] The mass concentration of the sodium hyaluronate solution in step (3) is 0.5%, and the volume ratio of the sodium hyaluronate solution, solution a and solution b is 5:2:2.
[0030] In the step (3), the ultrasonic time and frequency are 30 min and 40 kHz respectively, the drying temperature and time are 50° C. and 1 h respectively, and the pore size of the nanomembrane is 0.1 nm.
[0031] The preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 70° C. while stirring. After all the hyaluronate and carbomer are dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 35° C. while stirring, and sodium chloride is added, and the dressing is stirred for another 10 minutes.
[0032] The source of the carbomer is: Jiufenglong-9007-20-9.
[0033] Example 2
[0034] A medical sodium hyaluronate gel dressing, the medical sodium hyaluronate gel dressing is composed of the following raw materials in parts by weight: 0.25 parts of sodium hyaluronate, 0.05 parts of sodium chloride, 0.25 parts of carbomer, and 97.5 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps:
[0035] (1) placing sodium hyaluronate solid into an oxidizing solvent, mixing, heating and maintaining the temperature to obtain solution a;
[0036] (2) mixing sodium hyaluronate solid with a buffer solution, and then adding a degrading enzyme to obtain a solution b after degradation;
[0037] (3) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is ultrasonically mixed with solution a and solution b, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
[0038] The molecular weight of the sodium hyaluronate solid is 1.5 million. The solid-to-liquid ratio of the sodium hyaluronate solid to the oxidizing solvent in step (1) is 0.15 g:1 mL, wherein the oxidizing solvent is a hydrogen peroxide solution, the mass concentration of the hydrogen peroxide solution is 2.5%, and the insulation temperature and time are 72.5° C. and 27 h, respectively.
[0039] In the step (2), the solid-to-liquid ratio of sodium hyaluronate solid to buffer solution is 85 g:1 L, the mass ratio of sodium hyaluronate solid to degradation enzyme is 100:0.02, wherein the degradation enzyme is composed of β-glucuronidase and β-N-acetylglucosaminidase in a mass ratio of 1:1, and the degradation time and temperature are 1.5 h and 36° C., respectively.
[0040] The preparation method of the buffer solution in step (2) is as follows: disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride are dissolved in deionized water, and stirred at room temperature until all are dissolved to obtain a buffer solution.
[0041] The solid-liquid ratio of the total mass of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride to deionized water is 9.5g:1L, wherein the mass ratio of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride is 0.045:0.55:8.7.
[0042] The mass concentration of the sodium hyaluronate solution in step (3) is 1%, and the volume ratio of the sodium hyaluronate solution, solution a and solution b is 7.5:2:2.
[0043] In the step (3), the ultrasonic time and frequency are 40 min and 50 kHz respectively, the drying temperature and time are 55° C. and 1.5 h respectively, and the pore size of the nanomembrane is 0.2 nm.
[0044] The preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 85° C. while stirring. After all the hyaluronate and carbomer are dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 40° C. while stirring, and sodium chloride is added, and the dressing is stirred for another 10 minutes.
[0045] The source of the carbomer is: Jiufenglong-9007-20-9.
[0046] Example 3
[0047] A medical sodium hyaluronate gel dressing, the medical sodium hyaluronate gel dressing is composed of the following raw materials in parts by weight: 0.5 parts of sodium hyaluronate, 0.1 parts of sodium chloride, 5 parts of carbomer, and 100 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps:
[0048] (1) placing sodium hyaluronate solid into an oxidizing solvent, mixing, heating and maintaining the temperature to obtain solution a;
[0049] (2) mixing sodium hyaluronate solid with a buffer solution, and then adding a degrading enzyme to obtain a solution b after degradation;
[0050] (3) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is ultrasonically mixed with solution a and solution b, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
[0051] The molecular weight of the sodium hyaluronate solid is 2 million, the solid-to-liquid ratio of the sodium hyaluronate solid to the oxidizing solvent in the step (1) is 0.2 g:1 mL, wherein the oxidizing solvent is a hydrogen peroxide solution, the mass concentration of the hydrogen peroxide solution is 3%, and the insulation temperature and time are 75° C. and 230 h, respectively.
[0052] In the step (2), the solid-liquid ratio of sodium hyaluronate solid to buffer solution is 90 g:1 L, the mass ratio of sodium hyaluronate solid to degradation enzyme is 100:0.026, wherein the degradation enzyme is composed of β-glucuronidase and β-N-acetylglucosaminidase in a mass ratio of 1:1, and the degradation time and temperature are 2 h and 37° C., respectively.
[0053] The preparation method of the buffer solution in step (2) is as follows: disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride are dissolved in deionized water, and stirred at room temperature until all are dissolved to obtain a buffer solution.
[0054] The solid-liquid ratio of the total mass of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride to deionized water is 10g:1L, wherein the mass ratio of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride is 0.045:0.6:9.
[0055] The mass concentration of the sodium hyaluronate solution in step (3) is 1.5%, and the volume ratio of the sodium hyaluronate solution, solution a and solution b is 10:2:2.
[0056] In the step (3), the ultrasonic time and frequency are 45 min and 60 kHz respectively, the drying temperature and time are 60° C. and 2 h respectively, and the pore size of the nanomembrane is 0.4 nm.
[0057] The preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 90° C. while stirring. After all the hyaluronate and carbomer are dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 45° C. while stirring, and sodium chloride is added, and the dressing is stirred for another 10 minutes.
[0058] The source of the carbomer is: Jiufenglong-9007-20-9.
[0059] Comparative Example 1
[0060] On the basis of Example 3, a medical sodium hyaluronate gel dressing is provided, wherein the medical sodium hyaluronate gel dressing is composed of the following raw materials in parts by weight: 0.5 parts of sodium hyaluronate, 0.1 parts of sodium chloride, 5 parts of carbomer, and 100 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps:
[0061] (1) mixing sodium hyaluronate solid with a buffer solution, and then adding a degrading enzyme to obtain a solution b after degradation;
[0062] (2) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is then ultrasonically mixed with solution b, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
[0063] The solid-liquid ratio of the sodium hyaluronate solid to the buffer solution is 90 g:1 L, and the mass ratio of the sodium hyaluronate solid to the degradation enzyme is 100:0.026, wherein the degradation enzyme is composed of β-glucuronidase and β-N-acetylglucosaminidase in a mass ratio of 1:1, and the degradation time and temperature are 2 h and 37° C., respectively.
[0064] The preparation method of the buffer solution in step (1) is as follows: disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride are dissolved in deionized water, and stirred at room temperature until all are dissolved to obtain a buffer solution.
[0065] The solid-liquid ratio of the total mass of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride to deionized water is 10g:1L, wherein the mass ratio of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride is 0.045:0.6:9.
[0066] The mass concentration of the sodium hyaluronate solution in step (2) is 1.5%, and the volume ratio of the sodium hyaluronate solution to solution b is 10:2.
[0067] In the step (2), the ultrasonic time and frequency are 45 min and 60 kHz respectively, the drying temperature and time are 60° C. and 2 h respectively, and the pore size of the nanomembrane is 0.4 nm.
[0068] The preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 90° C. while stirring. After all the hyaluronate and carbomer are dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 45° C. while stirring, and sodium chloride is added, and the dressing is stirred for another 10 minutes.
[0069] The source of the carbomer is: Jiufenglong-9007-20-9.
[0070] Comparative Example 2
[0071] On the basis of Example 3, a medical sodium hyaluronate gel dressing is provided, wherein the medical sodium hyaluronate gel dressing is composed of the following raw materials in parts by weight: 0.5 parts of sodium hyaluronate, 0.1 parts of sodium chloride, 5 parts of carbomer, and 100 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps:
[0072] (1) placing sodium hyaluronate solid into an oxidizing solvent, mixing, heating and maintaining the temperature to obtain solution a;
[0073] (2) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is then ultrasonically mixed with solution a, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
[0074] The molecular weight of the sodium hyaluronate solid is 2 million, the solid-to-liquid ratio of the sodium hyaluronate solid to the oxidizing solvent in the step (1) is 0.2 g:1 mL, wherein the oxidizing solvent is a hydrogen peroxide solution, the mass concentration of the hydrogen peroxide solution is 3%, and the insulation temperature and time are 75° C. and 230 h, respectively.
[0075] The mass concentration of the sodium hyaluronate solution in step (2) is 1.5%, and the volume ratio of the sodium hyaluronate solution to solution a is 10:4.
[0076] In the step (2), the ultrasonic time and frequency are 45 min and 60 kHz respectively, the drying temperature and time are 60° C. and 2 h respectively, and the pore size of the nanomembrane is 0.4 nm.
[0077] The preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 90° C. while stirring. After all the hyaluronate and carbomer are dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 45° C. while stirring, and sodium chloride is added, and the dressing is stirred for another 10 minutes.
[0078] The source of the carbomer is: Jiufenglong-9007-20-9.
[0079] Comparative Example 3
[0080] On the basis of Example 3, the β-glucuronidase in step (2) of the preparation process of sodium hyaluronate was removed and replaced with an equal mass of β-N-acetylglucosaminidase, and the other conditions were consistent with Example 3.
[0081] Comparative Example 4
[0082] On the basis of Example 3, the β-N-acetylglucosamidase in step (2) of the preparation process of sodium hyaluronate was removed and replaced with an equal mass of β-glucuronidase, and the other conditions were consistent with Example 3.
[0083] 1. Performance Testing
[0084] Molecular weight detection: According to QB / T 4416-2012 "Sodium hyaluronate as raw material for cosmetics", the molecular weight of the sodium hyaluronate prepared in Example 3 and Comparative Examples 1-4 was detected. The test results are shown in Table 1;
[0085] Moisturizing test: The medical sodium hyaluronate gel dressings prepared in Example 3 and Comparative Examples 1-4 were used as samples. 45 effective volunteers were selected, aged 20 to 55 years old, and no products were used on the test area for 2 to 3 days. Before the test, the subjects uniformly cleaned the inner forearms of both hands, marked the 4×4cm test area, and evenly applied the sample on the left and right arms at a dosage of 3 mg / cm 2 The moisture content of the tested skin area was tested with a skin moisture tester before and 30 minutes, 1 hour, 3 hours, and 6 hours after the product was applied. Each area was tested 5 times in parallel, and the average value was used as the tester. The test of the same subject was completed by the same tester. All testers were in a room with constant temperature and humidity before and after the test. The moisturizing test formula is: Skin moisture increase (%) = (water content after application - water content before application) / water content before application × 100%. The test results are shown in Table 2.
[0086] Table 1 Molecular weight test results
[0087] Sample 2,000-10,000 10,000-300,000 300,000-600,000 ≥1 million Example 3 26.5% 24.8% 22.6% 26.1% Comparative Example 1 38.9% 10.17% 2.13% 48.8% Comparative Example 2 5.79% 9.84% 42.27% 42.1% Comparative Example 3 13.8% 12.4% 35.7% 38.1% Comparative Example 4 12.9% 13.% 36.1% 38%
[0088] As can be seen from Table 1, the molecular weight grades of Example 3 are very uniform, while the molecular weight grades of Comparative Examples 4 are too high or too low; in Comparative Example 1, the sodium hyaluronate solid is not degraded using an oxidizing solvent, and the molecular weight grades of 10,000-300,000 and 300,000-600,000 are significantly reduced; in Comparative Example 2, the sodium hyaluronate solid is not degraded using a degradation enzyme, and the molecular weight grades of 2,000-10,000 and 10,000-300,000 are reduced; in Comparative Examples 3-4, only β-glucuronidase or β-N-acetylglucosaminidase is added as the degradation enzyme, and the proportion of molecular weight grades of 2,000-10,000 and 10,000-300,000 is reduced.
[0089] Table 2 Moisturizing test results
[0090]
[0091] From the analysis of Table 2, it can be seen that the moisturizing effect of Example 3 is better than that of Comparative Examples 1-4, among which the moisturizing effect of Comparative Example 2 is the worst. In Comparative Example 1, since the proportion of molecular weight grades of 10,000-300,000 and 300,000-600,000 is relatively small, when the moisturizing effect of large molecular weight sodium hyaluronate on the skin surface fails, less water is absorbed under the skin surface, and thus the moisturizing property decreases; in Comparative Example 2, the proportion of small molecular weight sodium hyaluronate is the smallest, and the deep skin layer cannot be replenished with water, so after the water in the skin surface and lower layer is lost, the moisturizing effect decreases significantly at 3h; in Comparative Examples 3-4, the proportion of molecular weight grades of 2,000-10,000 and 10,000-300,000 is relatively small relative to the proportion of molecular weights of 300,000-600,000 and ≥1 million, but the difference is not as large as that of Comparative Example 2, so the reduction of water gradually decreases.
[0092] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment as above, it is not used to limit the present invention. Any technical personnel in this field can make some changes or modify the technical contents disclosed above into equivalent embodiments without departing from the scope of the technical solution of the present invention. However, any brief modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention are still within the scope of the technical solution of the present invention.
Claims
1. A medical sodium hyaluronate gel dressing, It is characterized in that The medical sodium hyaluronate gel dressing is composed of the following raw materials in parts by weight: 0.05-0.5 parts of sodium hyaluronate, 0.01-0.1 parts of sodium chloride, 0.5-5 parts of carbomer, and 95-100 parts of purified water. The preparation method of the sodium hyaluronate comprises the following steps: (1) placing sodium hyaluronate solid into an oxidizing solvent, mixing, heating and maintaining the temperature, to obtain solution a; (2) mixing sodium hyaluronate solid with a buffer solution, and then adding a degrading enzyme to obtain a solution b after degradation; (3) Sodium hyaluronate solid is mixed with deionized water to form a sodium hyaluronate solution, which is ultrasonically mixed with solution a and solution b, and then concentrated by a nano-membrane and dried to obtain sodium hyaluronate.
2. A medical sodium hyaluronate gel dressing according to claim 1, It is characterized in that The molecular weight of the sodium hyaluronate solid is 1-2 million, the solid-liquid ratio of the sodium hyaluronate solid to the oxidizing solvent in the step (1) is 0.1-0.2 g:1 mL, wherein the oxidizing solvent is a hydrogen peroxide solution, the mass concentration of the hydrogen peroxide solution is 2-3%, and the insulation temperature and time are 70-75° C. and 24-30 h, respectively.
3. A medical sodium hyaluronate gel dressing according to claim 1, It is characterized in that In the step (2), the solid-liquid ratio of sodium hyaluronate solid to buffer solution is 80-90 g:1 L, the mass ratio of sodium hyaluronate solid to degradation enzyme is 100:0.01-0.026, wherein the degradation enzyme is composed of β-glucuronidase and β-N-acetylglucosaminidase in a mass ratio of 1:1, and the degradation time and temperature are 1-2 h and 35-37 ° C, respectively.
4. A medical sodium hyaluronate gel dressing according to claim 1, It is characterized in that The preparation method of the buffer solution in step (2) is as follows: disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride are dissolved in deionized water, and stirred at room temperature until all are dissolved to obtain a buffer solution.
5. A medical sodium hyaluronate gel dressing according to claim 4, It is characterized in that The solid-liquid ratio of the total mass of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride to deionized water is 9-10g:1L, wherein the mass ratio of the disodium hydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate and sodium chloride is 0.045:0.5-0.6:8.5-9.
6. A medical sodium hyaluronate gel dressing according to claim 1, It is characterized in that The mass concentration of the sodium hyaluronate solution in step (3) is 0.5-1.5%, and the volume ratio of the sodium hyaluronate solution, solution a and solution b is 5-10:2:
2.
7. A medical sodium hyaluronate gel dressing according to claim 1, It is characterized in that In the step (3), the time and frequency of ultrasound are 30-45 min and 40-60 kHz respectively, the temperature and time of drying are 50-60° C. and 1-2 h respectively, and the pore size of the nanomembrane is 0.1-0.4 nm.
8. A method for preparing the medical sodium hyaluronate gel dressing according to any one of claims 1 to 7, It is characterized in that The preparation method of the sodium hyaluronate gel dressing is as follows: sodium hyaluronate and carbomer are added to purified water and stirred to disperse, and the temperature is raised to 85°C±5°C while stirring. After all the hyaluronate and carbomer are dissolved, the temperature is kept stirring for 20 minutes, and then the temperature is cooled to 40°C±5°C while stirring, and sodium chloride is added, and the dressing is stirred for another 10 minutes.
Citation Information
Patent Citations
Liquid dressing used after laser surgery and preparation method of liquid dressing
CN110755679A
Sodium hyaluronate with full molecular weight distribution as well as preparation method and application of sodium hyaluronate
CN113512134A
Hyaluronic acid oligosaccharide composition as well as preparation method and application thereof
CN115944549A
Hydrophobic solution composition as well as preparation method and application thereof
CN116637043A
Sodium hyaluronate dressing for skin barrier repair and preparation method thereof
CN118384321A
Cited By
Sodium hyaluronate dressing for wet healing and repairing of skin and preparation method of sodium hyaluronate dressing
CN122624732A
A sodium hyaluronate dressing for moist skin healing and repair and its preparation method
CN122624732B
